BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

632 related articles for article (PubMed ID: 18096470)

  • 1. The pathogenesis of chronic immune thrombocytopenic purpura.
    McMillan R
    Semin Hematol; 2007 Oct; 44(4 Suppl 5):S3-S11. PubMed ID: 18096470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pathogenesis of chronic immune (idiopathic) thrombocytopenic purpura.
    McMillan R
    Semin Hematol; 2000 Jan; 37(1 Suppl 1):5-9. PubMed ID: 10676917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro.
    Chang M; Nakagawa PA; Williams SA; Schwartz MR; Imfeld KL; Buzby JS; Nugent DJ
    Blood; 2003 Aug; 102(3):887-95. PubMed ID: 12676790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of chronic immune thrombocytopenic purpura.
    Cines DB; McMillan R
    Curr Opin Hematol; 2007 Sep; 14(5):511-4. PubMed ID: 17934360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies and autoantigens in chronic immune thrombocytopenic purpura.
    McMillan R
    Semin Hematol; 2000 Jul; 37(3):239-48. PubMed ID: 10942218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of autoantibody specificity and response to intravenous immunoglobulin G therapy in immune thrombocytopenia: a multicenter cohort study.
    Peng J; Ma SH; Liu J; Hou Y; Liu XM; Niu T; Xu RR; Guo CS; Wang XM; Cheng YF; Ni H; Hou M
    J Thromb Haemost; 2014 Apr; 12(4):497-504. PubMed ID: 24517219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibody-mediated complement activation on platelets is a common finding in patients with immune thrombocytopenic purpura (ITP).
    Najaoui A; Bakchoul T; Stoy J; Bein G; Rummel MJ; Santoso S; Sachs UJ
    Eur J Haematol; 2012 Feb; 88(2):167-74. PubMed ID: 21985182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and pathophysiology of immune thrombocytopenic purpura.
    Gernsheimer T
    Eur J Haematol Suppl; 2008 Feb; (69):3-8. PubMed ID: 18211567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and/or decreased platelet production.
    Nugent D; McMillan R; Nichol JL; Slichter SJ
    Br J Haematol; 2009 Sep; 146(6):585-96. PubMed ID: 19466980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of antiplatelet autoantibodies on megakaryocytopoiesis.
    McMillan R; Nugent D
    Int J Hematol; 2005 Feb; 81(2):94-9. PubMed ID: 15765775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet autoantibody specificity and response to rhTPO treatment in patients with primary immune thrombocytopenia.
    Yu Y; Hou Y; Zhao Y; Zhou H; Jing F; Liu Y; Peng J; Liu X; Hou M
    Br J Haematol; 2021 Jul; 194(1):191-194. PubMed ID: 33993469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Both splenic CD5(+) B and CD5(-) B cells produce platelet glycoprotein-specific autoantibodies in chronic ITP.
    Hou M; Lv B; He Q; Lu L; Shi Y; Ji X; Ma D; Zhang M
    Thromb Res; 2003 Apr; 110(1):1-5. PubMed ID: 12877901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired proplatelet formation in immune thrombocytopenia: a novel mechanism contributing to decreased platelet count.
    Lev PR; Grodzielski M; Goette NP; Glembotsky AC; Espasandin YR; Pierdominici MS; Contrufo G; Montero VS; Ferrari L; Molinas FC; Heller PG; Marta RF
    Br J Haematol; 2014 Jun; 165(6):854-64. PubMed ID: 24673454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathophysiology of ITP revisited: ineffective thrombopoiesis and the emerging role of thrombopoietin receptor agonists in the management of chronic immune thrombocytopenic purpura.
    Gernsheimer TB
    Hematology Am Soc Hematol Educ Program; 2008; ():219-26. PubMed ID: 19074086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Splenic macrophages maintain the anti-platelet autoimmune response via uptake of opsonized platelets in patients with immune thrombocytopenic purpura.
    Kuwana M; Okazaki Y; Ikeda Y
    J Thromb Haemost; 2009 Feb; 7(2):322-9. PubMed ID: 18826388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibody against integrin α
    Zeng DF; Chen F; Wang S; Chen SL; Xu Y; Shen MQ; Du CH; Wang C; Kong PY; Cheng TM; Su YP; Wang JP
    J Thromb Haemost; 2018 Sep; 16(9):1843-1856. PubMed ID: 29953749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Participation of bonth splenic CD(5)(+) and CD(5)(-) B lymphocytes in production of platelet glycoprotein-specific autoantibodies in chronic ITP].
    Lu B; Hou M; Lu L; Shi Y; He Q; Ma D; Zhang M
    Zhonghua Xue Ye Xue Za Zhi; 2002 Sep; 23(9):460-2. PubMed ID: 12482355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiplatelet antibodies in chronic adult immune thrombocytopenic purpura: assays and epitopes.
    McMillan R
    J Pediatr Hematol Oncol; 2003 Dec; 25 Suppl 1():S57-61. PubMed ID: 14668642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura. Role in production of anti-platelet autoantibody.
    Kuwana M; Kaburaki J; Ikeda Y
    J Clin Invest; 1998 Oct; 102(7):1393-402. PubMed ID: 9769332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of hypoxia-inducible factor-1α contributes to impaired megakaryopoiesis in immune thrombocytopenia.
    Qi J; You T; Pan T; Wang Q; Zhu L; Han Y
    Thromb Haemost; 2017 Oct; 117(10):1875-1886. PubMed ID: 28771276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.